Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 121-128

  Kothari, Vishal ^a   Mulherkar, Rita ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemosensitivity; Cisplatin; Cyclin D1; Head and neck cancer; HNSCC; RNAi

Indexed keywords

CISPLATIN; CYCLIN D1; PLASMID VECTOR; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE PROGRESSION; CELL KILLING; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; CISPLATIN; COLONY-FORMING UNITS ASSAY; CYCLIN D1; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84855662114     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hamada GS, Bos AJ, Kasuga H and Hirayama T: Comparative epidemiology of oral cancer in Brazil and India. Tokai J Exp Clin Med 16: 63-72, 1991.
2. Sankaranarayanan R: Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 69: 325-330, 1990.
3. Henriksson E, Baldetorp B, Borg A, Kjellen E, Akervall J, Wennerberg J and Wahlberg P: p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol 45: 300-305, 2006. (Pubitemid 43675571)
4. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
5. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
6. Motokura T and Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev 3: 5-10, 1993. (Pubitemid 23079640)
7. Hunter T and Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
8. Biliran H Jr., Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH and Liao JD: Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res 11: 6075-6086, 2005. (Pubitemid 41170340)
9. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F and Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389, 1997. (Pubitemid 27029903)
10. Milas L, Akimoto T, Hunter NR, Mason KA, Buchmiller L, Yamakawa M, Muramatsu H and Ang KK: Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas. Int J Radiat Oncol Biol Phys 52: 514-521, 2002. (Pubitemid 34170856)
11. Kalish LH, Kwong RA, Cole IE, Gallagher RM, Sutherland RL and Musgrove EA: Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin Cancer Res 10: 7764-7774, 2004. (Pubitemid 39557542)
12. Stendahl M, Kronblad A, Ryden L, Emdin S, Bengtsson NO and Landberg G: Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer 90: 1942-1948, 2004. (Pubitemid 38746334)
13. Sauter ER, Herlyn M, Liu SC, Litwin S and Ridge JA: Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Clin Cancer Res 6: 654-660, 2000. (Pubitemid 30111491)
14. Wang MB, Yip HT and Srivatsan ES: Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Laryngoscope 111: 982-988, 2001. (Pubitemid 32523704)
15. Shuai XM, Han GX, Wang GB and Chen JH: Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells. World J Gastroenterol 12: 1766-1769, 2006.
16. Hiroi N, Funahashi A and Kitano H: Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. Cancer Gene Ther 13: 7-12, 2006. (Pubitemid 41816344)
17. Oridate N, Kim HJ, Xu X and Lotan R: Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin. Cancer Biol Ther 4: 318-323, 2005. (Pubitemid 41351293)
18. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408: 307-310, 2000.
19. Coco Martin JM, Balkenende A, Verschoor T, Lallemand F and Michalides R: Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res 59: 1134-1140, 1999. (Pubitemid 29135977)
20. Mulherkar R, Goud AP, Wagle AS, Naresh KN, Mahimkar MB, Thomas SM, Pradhan SA and Deo MG: Establishment of a human squamous cell carcinoma cell line of the upper aerodigestive tract. Cancer Lett 118: 115-121, 1997. (Pubitemid 27397232)
21. Ambade A and Mulherkar R: Adoptive T cell transfer augments IL-2 mediated tumour regression in a HNSCC xenograft nude mouse model. Cancer Lett 272: 316-324, 2008.
22. Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262, 1998.
23. Reed SI: Control of the Gl/S transition. Cancer Surv 29: 7-23, 1997.
24. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S and Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8: 51-60, 1997.
25. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630, 1995.
26. Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231, 2001. (Pubitemid 33741897)
27. Feng Z, Guo W, Zhang C, Xu Q, Zhang P, Sun J, Zhu H, Wang Z, Li J, Wang L, Wang B, Ren G, Ji T, Tu W, Yang X, Qiu W, Mao L, Zhang Z and Chen W: CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. PLoS One 6: e26399, 2011.
28. Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, Sharp S, Chaplin T, Xue L, McIntyre A, Shan L, Powles T, Oliver RT, Young BD, Shipley J, Berney DM, Joel SP and Lu YJ: The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers. Am J Pathol 176: 2607-2615, 2010.
29. Edinger AL and Thompson CB: Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 13: 2276-2288, 2002. (Pubitemid 34831333)
30. Fingar DC, Salama S, Tsou C, Harlow E and Blenis J: Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16: 1472-1487, 2002. (Pubitemid 34686329)
31. Nyati MK, Morgan MA, Feng FY and Lawrence TS: Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer 6: 876-885, 2006. (Pubitemid 44629899)
32. Sakamaki T, Casimire MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C and Pestell R: Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 26: 5449-5469, 2006. (Pubitemid 44036212)
33. Saini SS and Klein MA: Targeting Cyclin D1 in Non-small Cell Lung Cancer and Mesothelioma Cells by Antisense Oligonucleotides. Anticancer Res 31: 3683-3690, 2011.
34. Brummelkamp T R, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002. (Pubitemid 34408678)
35. Zhou X, Zhang Z, Yang X, Chen W and Zhang P: Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity. Int J Cancer 124: 483-489, 2009.
36. Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, Kunkel TA, van Harn T, Xia B, Correll M, Quackenbush J, Livingston DM, Gygi SP and Sicinski P: A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474: 230-234, 2011.